tirzepatide with cagrilintide Comparative Weight Loss CagriSema, Semaglutide, Cagrilintide, and cagrilintide tirzepatide combination + Peptide

Of note, SGLT2 inhibitors also reduce cardiovascular mortality or hospitalization for heart failure, thus showing benefits across the cardiorenal axis

They are also low in calories and volume, matching the reduced appetite caused by GLP-1 medications

This is not an argument against GLP-1 drugs

Excessive weight often exacerbates diabetes symptoms and increases the risk of complications

You may have recently heard of weight loss medications like Ozempic or other GLP-1 agonists

Given the prolonged duration and high prevalence of LC-related psychological symptoms, integrating psychological health care into comprehensive LC treatment plans is essential (133)